Asthma Drug Montelukast Tested as Alzheimer’s Treatment in Proof-of-concept Trial
News
Canada’s IntelGenx has launched a Phase 2a proof-of-concept trial to explore whether the old asthma medication montelukast may be an option for treating Alzheimer’s disease. The idea that montelukast — ... Read more